Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis-Reference-Cited by-同舟云学术

Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis

Published:2004-06 Issue:3 Volume:23 Page:347-353
ISSN:0261-5614
Container-title:Clinical Nutrition
language:en
Short-container-title:Clinical Nutrition

Author:

Laiho Kirsi M,Gavin Joan,Murphy Jane L,Connett Gary J,Wootton Stephen A

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine,Nutrition and Dietetics

Reference21 articles.

1. Assessment of pancreatic function in screened infants with cystic fibrosis;Gaskin;Pediatr Pulmonol,1991

2. Control of malabsorption in cystic fibrosis;Littlewood;Paediatr Drugs,2000

3. Energy content of stools in normal healthy controls and patients with cystic fibrosis;Murphy;Arch Dis Child,1991

4. Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis;Murphy;Arch Dis Child,1998

5. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance & Widdowson's: The composition of food. The Royal Society of Chemistry and the Ministry of Agriculture, Fisheries and Food, 5th revised extended ed, 1991.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019;Clinical Pharmacokinetics;2020-08-18

2. Nutrition and Cystic Fibrosis;Nutrition in the Prevention and Treatment of Disease;2017

3. Pancreatic Insufficiency;Nutrition in Cystic Fibrosis;2015

4. Nutrition and Cystic Fibrosis;Nutrition in the Prevention and Treatment of Disease;2013

5. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies;Drug Design, Development and Therapy;2012-06